Targeted Drug Delivery for Breast Cancer using Functionalized Liposomes: Preparation Methods, Challenges, and Clinical Translation
- PMID: 40764411
- DOI: 10.1208/s12249-025-03206-4
Targeted Drug Delivery for Breast Cancer using Functionalized Liposomes: Preparation Methods, Challenges, and Clinical Translation
Abstract
Breast cancer continues to be a major cause to cancer-related deaths globally, highlighting the urgent need for more targeted and efficient treatment approaches. This review focuses on targeted drug delivery systems using functionalized liposomes, which have emerged as promising nanocarriers due to their ability to improve drug solubility, stability, and site-specific delivery. They alter a drug's pharmacokinetics and biodistribution to improve pharmacological efficacy while minimizing systemic toxicity. The review provides a comprehensive overview of various liposome preparation methods, highlighting their advantages, limitations, and suitability for drug encapsulation. We also discuss surface modifications for active tumor targeting and overcoming challenges in the tumor microenvironment. Clinical translation hurdles, including scalability, reproducibility, and regulatory concerns, are also examined. This review concludes with an overview of current advancements and future perspectives on optimizing functionalized liposomes for personalized breast cancer therapy. The insights aim to guide the design of more effective liposomal formulations for clinical use.
Keywords: Breast cancer; Chemotherapeutic drug; Encapsulation; Functionalized liposomes; Malignancies; Targeted drug delivery.
© 2025. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
Conflict of interest statement
Declarations. Ethics Approval and Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing interest: The authors confirm that they have no recognized financial conflicts or personal associations that may have influenced the findings presented in this paper.
References
-
- Saman H, Raza SS, Uddin S, et al. Inducing Angiogenesis, a Key Step in Cancer Vascularization, and Treatment Approaches. Cancers. 2020;12:1172. https://doi.org/10.3390/cancers12051172 . - DOI - PubMed - PMC
-
- Hooper L, Anderson AS, Birch J, et al. Public awareness and healthcare professional advice for obesity as a risk factor for cancer in the UK: a cross-sectional survey. J Public Health. 2018;40:797–805. https://doi.org/10.1093/pubmed/fdx145 . - DOI
-
- Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clinicians. 2021;71:209–49. https://doi.org/10.3322/caac.21660 . - DOI
-
- Conway K, Edmiston SN, Parrish E, et al. Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study. Breast Cancer Res Treat. 2017;163:349–61. https://doi.org/10.1007/s10549-017-4178-8 . - DOI - PubMed - PMC
-
- Shraim R, Farran MZ, He G, et al. Systematic review on gene–sun exposure interactions in skin cancer. Molec Gen & Gen Med. 2023;11:e2259. https://doi.org/10.1002/mgg3.2259 . - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
